Gobernanza de riesgos de la nanomedicinael caso europeo
- Concha Martínez Vidal (dir. congr.)
- José L. Falguera López (dir. congr.)
- José M. Sagüillo (dir. congr.)
- Víctor M. Verdejo Aparicio (dir. congr.)
- Martín Pereira Fariña (dir. congr.)
Editorial: Servicio de Publicaciones e Intercambio Científico ; Universidad de Santiago de Compostela
ISBN: 978-84-9887-939-1
Año de publicación: 2012
Páginas: 424-431
Congreso: Sociedad de Lógica, Metodología y Filosofía de la Ciencia en España. Congreso (7. 2012. Santiago de Compostela)
Tipo: Aportación congreso
Resumen
Nanomedicine is the application of nanotechnology to the study and improvement of human health, and a research area of high economic significance as well. But it also implies risks for human health and the environment, so the European Union claims to be committed to its “responsible development”. However, there are different opinions in the EU about how nanomedicine—and nanotechnology in general—should be regulated. This paper will analyze critically two of the more relevant opinions.